APLM

Apollomics Inc

22.52

Sep 17 • 3:59 PM ET +0.42 (1.90%)

22.58

Aftermarket • 7:30 PM ET +0.06 (0.24%)

Healthcare Biotechnology USA Micro NASD

Peers: SNTI BRNS CRVO IGC NRSN PLRZ SER SKYE GRDX LSTA

| Held by: CHNA

Scroll to Statements

Index	-
Market Cap	65.66M
Enterprise Value	-
Income	-10.94M
Sales	8.50M
Book/sh	-
Cash/sh	1.13
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	14
IPO	Nov 26, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	7.73
P/B	-
P/C	20.02
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	-
Current Ratio	0.96
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / Yes

EPS (ttm)	-7.57
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	50.29% 18.23%
Sales past 3/5Y	- -
EPS Y/Y TTM	86.10%
Sales Y/Y TTM	-
EPS Q/Q	-1224.24%
Sales Q/Q	-
Earnings	Apr 27 BMO
EPS/Sales Surpr.	- -

Insider Own	75.60%
Insider Trans	36.00%
Inst Own	0.37%
Inst Trans	96.31%
ROA	-110.43%
ROE	-1305.37%
ROIC	-
Gross Margin	-
Oper. Margin	-304.27%
Profit Margin	-128.69%
SMA20	-10.22%
SMA50	5.78%
SMA200	23.01%
Trades

Shs Outstand	2.92M
Shs Float	0.71M
Short Float	1.04%
Short Ratio	0.30
Short Interest	0.01M
52W High	42.12 -46.52%
52W Low	10.01 125.13%
Volatility	6.98% 7.52%
ATR (14)	1.89
RSI (14)	45.83
Beta	1.57
Rel Volume	0.12
Avg Volume	25.11K
Volume	2,981

Perf Week	-5.60%
Perf Month	-5.83%
Perf Quarter	61.35%
Perf Half Y	15.51%
Perf YTD	20.49%
Perf Year	22.20%
Perf 3Y	-94.24%
Perf 5Y	-
Perf 10Y	-
Recom	1.00
Target Price	50.00
Prev Close	22.10
Price	22.52
Change %	1.90%

Aug-11-26 04:35PM	Apollomics Announces $10 Million Private Placement Transaction (GlobeNewswire) -6.06%
Jul-13-26 08:00AM	Apollomics Regains Full Compliance with Nasdaq Listing Requirements (GlobeNewswire) -25.01%
Jun-24-26 04:15PM	Apollomics Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement and Updates Rights for Vebreltinib (APL-101) in Asia (GlobeNewswire) +7.32%
Apr-27-26 08:00AM	Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress (GlobeNewswire)
Apr-01-26 07:00AM	Apollomics Inc. Announces $2.0 Million Bridge Financing (GlobeNewswire) -7.13%
04:05PM	Loading…
Dec-22-25 04:05PM	Apollomics Reports First Half 2025 Financial Results (GlobeNewswire) +10.55% -6.81%
Nov-19-25 05:38PM	Apollomics Announces Settlement of Cayman Litigation (GlobeNewswire) -17.51%
Nov-17-25 11:00PM	Apollomics Announces Changes to its Board of Directors and Composition of Committees (GlobeNewswire) -12.59% -14.50%
Oct-15-25 02:36PM	Apollomics Announces Continued Listing on The Nasdaq Stock Market Following Hearing Cancellation (GlobeNewswire) +5.79%

Apollomics, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of oncology therapies to address unmet medical needs. The company was founded by Liang Yu Guo and Sanjeev Redkar in May 2015 and is headquartered in Foster City, CA.

CEOHung Wen Chen

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
LIN PETER KUAN-HOW	Chief Financial Officer	Sep 15 '26	Option Exercise	0.00	10,000	0	58,979	Sep 17 08:55 PM
CHEN HONG-JUNG	Director	Sep 15 '26	Option Exercise	0.00	500	0	4,120	Sep 17 08:49 PM
Chen Yi-Kuei	Chief Operating Officer	Sep 15 '26	Option Exercise	0.00	5,000	0	20,100	Sep 17 08:48 PM
TSAI HSIEN-SHU	Director	Sep 15 '26	Option Exercise	0.00	500	0	2,000	Sep 17 08:47 PM
Yen Hung Hsien	Director	Sep 15 '26	Option Exercise	0.00	500	0	500	Sep 17 08:44 PM
Chen Hung-Wen	Chief Executive Officer	Sep 15 '26	Option Exercise	0.00	5,000	0	423,334	Sep 17 08:38 PM
Huang Ya-Chi	Director	Aug 17 '26	Option Exercise	0.00	500	0	1,500	Aug 24 08:51 PM
Chen Yi-Kuei	Chief Operating Officer	Aug 14 '26	Buy	15.00	20,000	300,000	121,248	Aug 17 07:32 PM
LIN PETER KUAN-HOW	Chief Financial Officer	Aug 14 '26	Buy	15.00	26,667	400,005	48,979	Aug 17 07:23 PM
Chen Hung-Wen	Chief Executive Officer	Aug 14 '26	Buy	15.00	266,667	4,000,005	1,029,695	Aug 17 07:13 PM
Chen Hung-Wen	Chief Executive Officer	Aug 14 '26	Buy	13.15	270,000	3,549,999	418,334	Aug 17 07:13 PM
LIN PETER KUAN-HOW	Chief Financial Officer	Jun 15 '26	Option Exercise	0.00	10,000	0	25,900	Jun 17 07:31 PM
Chen Hung-Wen	Chief Executive Officer	Jun 15 '26	Option Exercise	0.00	5,000	0	148,334	Jun 16 05:11 PM
CHU YI-AN	Director	Jun 15 '26	Option Exercise	0.00	500	0	1,500	Jun 16 05:09 PM
CHEN HONG-JUNG	Director	Jun 15 '26	Option Exercise	0.00	500	0	3,620	Jun 16 05:08 PM
TSAI HSIEN-SHU	Director	Jun 15 '26	Option Exercise	0.00	500	0	1,500	Jun 16 05:05 PM
Chen Yi-Kuei	Chief Operating Officer	Jun 15 '26	Option Exercise	0.00	5,000	0	15,000	Jun 16 05:01 PM
Jan Chen-Huan	Director	Jun 15 '26	Option Exercise	0.00	500	0	1,500	Jun 16 05:01 PM
Huang Ya-Chi	Director	May 17 '26	Option Exercise	0.00	500	0	1,000	May 19 12:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

APLM

Apollomics Inc

Upgrade your Finviz experience